Stocks and Investing
Stocks and Investing
Thu, January 19, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Patrick Trucchio Maintained (ATAI) at Strong Buy with Decreased Target to $20 on, Jan 19th, 2023
Patrick Trucchio of HC Wainwright & Co., Maintained "Atai Life Sciences N.V." (ATAI) at Strong Buy with Decreased Target from $50 to $20 on, Jan 19th, 2023.
Patrick has made no other calls on ATAI in the last 4 months.
There are 3 other peers that have a rating on ATAI. Out of the 3 peers that are also analyzing ATAI, 0 agree with Patrick's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Patrick
- Neena Bitritto-Garg of "Citigroup" Maintained at Strong Buy with Decreased Target to $10 on, Monday, January 9th, 2023
- Elemer Piros of "EF Hutton" Maintained at Strong Buy with Decreased Target to $15 on, Friday, January 6th, 2023
- Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $18 on, Tuesday, November 1st, 2022
Contributing Sources